493 related articles for article (PubMed ID: 24731445)
21. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
22. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin system within the diabetic podocyte.
Márquez E; Riera M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
[TBL] [Abstract][Full Text] [Related]
24. Activation of the renin-angiotensin system within podocytes in diabetes.
Yoo TH; Li JJ; Kim JJ; Jung DS; Kwak SJ; Ryu DR; Choi HY; Kim JS; Kim HJ; Han SH; Lee JE; Han DS; Kang SW
Kidney Int; 2007 May; 71(10):1019-27. PubMed ID: 17361112
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
28. Influence of tacrolimus on podocyte injury inducted by angiotensin II.
Shengyou Y; Li Y; Zhihong H; Yuanyuan M
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):260-6. PubMed ID: 25650384
[TBL] [Abstract][Full Text] [Related]
29. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
Ma R; Liu L; Jiang W; Yu Y; Song H
Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
[TBL] [Abstract][Full Text] [Related]
30. VEGF regulates TRPC6 channels in podocytes.
Thilo F; Liu Y; Loddenkemper C; Schuelein R; Schmidt A; Yan Z; Zhu Z; Zakrzewicz A; Gollasch M; Tepel M
Nephrol Dial Transplant; 2012 Mar; 27(3):921-9. PubMed ID: 21868397
[TBL] [Abstract][Full Text] [Related]
31. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
[TBL] [Abstract][Full Text] [Related]
33. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
35. The role of TRPC6 in oxidative stress-induced podocyte ischemic injury.
Zhao B; Yang H; Zhang R; Sun H; Liao C; Xu J; Meng K; Jiao J
Biochem Biophys Res Commun; 2015 May; 461(2):413-20. PubMed ID: 25896763
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Yu Y; Zhang L; Xu G; Wu Z; Li Q; Gu Y; Niu J
Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548
[TBL] [Abstract][Full Text] [Related]
37. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
38. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
39. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]